Your browser doesn't support javascript.
loading
Implant Survival in Immediately Loaded Full-Arch Rehabilitations Following an Anatomical Classification System-A Retrospective Study in 1200 Edentulous Jaws.
Caramês, João Manuel Mendez; Marques, Duarte Nuno da Silva; Caramês, Gonçalo Bartolo; Francisco, Helena Cristina Oliveira; Vieira, Filipe Araújo.
Affiliation
  • Caramês JMM; Instituto de Implantologia, Avenida Columbano Bordalo Pinheiro, 1070-064 Lisbon, Portugal.
  • Marques DNDS; Faculdade de Medicina Dentária, Universidade de Lisboa, 1600-277 Lisbon, Portugal.
  • Caramês GB; LIBPhys-FCT UID/FIS/04559/2013, Faculty of Dental Medicine, University of Lisbon, 1600-277 Lisbon, Portugal.
  • Francisco HCO; Instituto de Implantologia, Avenida Columbano Bordalo Pinheiro, 1070-064 Lisbon, Portugal.
  • Vieira FA; Faculdade de Medicina Dentária, Universidade de Lisboa, 1600-277 Lisbon, Portugal.
J Clin Med ; 10(21)2021 Nov 04.
Article in En | MEDLINE | ID: mdl-34768687
This retrospective study analyzed implant survival of immediate implant-supported fixed complete denture (IFCD) treatment options (TOs) based on the level of alveolar atrophy (CC). Records of 882 patients receiving a total of 6042 implants at one private referral clinic between 2004 and 2020 were considered. The mean follow-up period was 3.8 ± 2.7 years. Cumulative implant survival rates (CSRs) were analyzed as a function of CCs and TOs according to Mantel-Haenszel and Mantel-Cox. Hazard risk ratios for implant loss were compared using Cox regression. Confounding factors were identified using mixed Cox regression models. The 2- and 5-year CSRs were 98.2% and 97.9%, respectively. Maxillary 2- and 5-year CSRs were lower (97.7% and 97.3%) compared to mandibular CSRs (99.8% and 98.6%) (p = 0.030 and 0.0020, respectively). The CC did not influence CSRs of IFCDs in the mandible (p = 0.1483 and 0.3014, respectively) but only in the maxilla (p = 0.0147 and 0.0111), where CSRs decreased with increasing atrophy. TOs did not statistically differ in terms of survival rate for a given level of alveolar atrophy. The adaption of IFCD treatments to the level of atrophy and patient-specific risk factors can result in high CSRs, even at different levels of bone atrophy.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: J Clin Med Year: 2021 Document type: Article Affiliation country: Portugal Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: J Clin Med Year: 2021 Document type: Article Affiliation country: Portugal Country of publication: Switzerland